Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$433.03 +0.43 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

Madrigal Pharmaceuticals (MDGL) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Madrigal Pharmaceuticals' Return on Capital Employed [ROCE] came in at -17.24% for Q3 2026, up 21.31 percentage points from -38.56% a year earlier and up 20.19 percentage points from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Madrigal Pharmaceuticals' Return on Capital Employed [ROCE] was -35.70%, up 38.38 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased in each of the last three years, with a five-year change of +29.30 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -74.08% in FY2024 (+25.27 pp), -99.34% in FY2023 (+45.95 pp), -145.29% in FY2022 (-26.03 pp) and -119.26% in FY2021 (-54.26 pp).
  • The Q3 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q2 2019.
  • Year-over-year, Return on Capital Employed [ROCE] has increased for 15 consecutive quarters, with an average year-over-year change of +21.92 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 144.10 percentage points), and the weakest in Q3 2022 (a drop of 211.86 percentage points).
  • Business Quant data shows MDGL's Return on Capital Employed [ROCE] at -37.44% (Q2 2026), -34.63% (Q1 2026) and -29.99% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Madrigal Pharmaceuticals 12.65 Bn 9.06 Bn 393.45 Mn -17.24%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -17.24%
Jun 30, 2026 -37.44%
Mar 31, 2026 -34.63%
Dec 31, 2025 -29.99%
Sep 30, 2025 -38.56%
Jun 30, 2025 -38.27%
Mar 31, 2025 -49.89%
Dec 31, 2024 -56.04%
Sep 30, 2024 -60.31%
Jun 30, 2024 -54.90%
Mar 31, 2024 -60.80%
Dec 31, 2023 -118.64%
Sep 30, 2023 -204.41%
Jun 30, 2023 -151.78%
Mar 31, 2023 -126.15%
Dec 31, 2022 -202.86%
Sep 30, 2022 -307.99%
Jun 30, 2022 -188.63%
Mar 31, 2022 -144.19%
Dec 31, 2021 -114.28%
API Access

Madrigal Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MDGL&period=max&api_key=YOUR_API_KEY